Get access

In vivo genotoxicity and cytotoxicity assessment of a novel quinoxalinone with trichomonacide activity

Authors

  • Norma Rivera,

    Corresponding author
    1. Laboratorio de Malariología, Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, México, DF
    • Correspondence to: Laboratorio de Malariología, Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, México DF, 04510. E-mail: normariv@hotmail.com

    Search for more papers by this author
  • Marcela Rojas,

    1. Departamento de Biología Celular y Tisular, Facultad de Medicina, Universidad Nacional Autónoma de México, México, DF
    Search for more papers by this author
  • Armando Zepeda,

    1. Departamento de Biología Celular y Tisular, Facultad de Medicina, Universidad Nacional Autónoma de México, México, DF
    Search for more papers by this author
  • Filiberto Malagón,

    1. Laboratorio de Malariología, Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, México, DF
    Search for more papers by this author
  • Vicente J. Arán,

    1. Instituto de Química Médica, CSIC, Madrid, España
    Search for more papers by this author
    • Contact for drug design and synthesis method. E-mail: ymarrero77@yahoo.es (Y.M.-P.) and vjaran@iqm.csic.es (V. J.A.).
  • Yovani Marrero-Ponce,

    1. Unit of Computer-Aided Molecular “Biosilico” Discovery and Bioinformatic Research, Faculty of Chemistry-Pharmacy, Universidad Central “Marta Abreu” de Las Villas, Santa Clara, Villa Clara, Cuba
    Search for more papers by this author
    • Contact for drug design and synthesis method. E-mail: ymarrero77@yahoo.es (Y.M.-P.) and vjaran@iqm.csic.es (V. J.A.).
  • Ernesto Rivera,

    1. Departamento de Ciencias Naturales, Universidad Autónoma Metropolitana, Unidad Cuajimalpa, México, DF
    Search for more papers by this author
  • Teresa I. Fortoul

    1. Departamento de Biología Celular y Tisular, Facultad de Medicina, Universidad Nacional Autónoma de México, México, DF
    Search for more papers by this author

ABSTRACT

The compound VAM2-6 (1-methyl-7-nitro-4-(5-(piperidin-1-yl)pentyl)-3,4-dihydroquinoxalin-2(1H)-one) has previously been shown to have an in vitro efficacy of 100% at a concentration of 100 µg ml–1 against Trichomonas vaginalis, a protozoon parasite that causes the sexually transmitted disease trichomoniasis. Because VAM2-6 is a quinoxaline derivative and given the lack of studies on the genotoxic activity of this compound, the present study was undertaken to evaluate its ability to induce DNA damage in the peripheral blood of mice using single-cell gel electrophoresis (SCGE or comet assay) and the micronucleus (MN) assay. Cell viability was assessed using a fluorochrome-mediated viability test. The compound was tested on CD1 mice at 60, 40 and 10 mg kg–1 body weight administrated intraperitoneal (i.p.) in a single dose. Peripheral blood samples were collected 24 and 48 h after treatment. N-Ethyl-N-nitrosourea (ENU) was used as a positive control for the comet and micronucleus assays. The results showed that i.p. VAM2-6 induced single-strand DNA breaks and increased the average number of micronuclei in the treated mice in a dose-dependent manner at 60, 40 and 10 mg kg–1. Cell viability decreased at 24 h but recovered at 48 h for all three evaluated doses. Therefore, the chemical structure of VAM2-6 should be modified to reduce its genotoxic potential. Copyright © 2012 John Wiley & Sons, Ltd.

Ancillary